Bristol-Myers Squibb’s Price Target From Berenberg Lifted to $58 From $57 Bristol-Myers Squibb’s Price Target From Berenberg Lifted to $58 From $57
Estee Lauder Q1 Tops Street on EPS and Revenue; Guides Q2 EPS Below Street Estee Lauder Q1 Tops Street on EPS and Revenue; Guides Q2 EPS Below Street
Pepsico Acquires Sparkling Water Maker SodaStream For $3.2 Billion in All-Cash Deal Pepsico Acquires Sparkling Water Maker SodaStream For $3.2 Billion in All-Cash Deal
Apple to Face ‘Material’ Disappointment in 2019 as iPhone Revenues Will Decline 8%, New Street Says Apple to Face ‘Material’ Disappointment in 2019 as iPhone Revenues Will Decline 8%, New Street Says

Stock News

Bunge Reports Q3 EPS Beat, Misses on Revenue; Appoints New Board Members, Forms Strategic Review Committee

Bunge (BG) reported Wednesday financial results for Q3, with better-than-expected earnings and revenue that fell short of analysts’ estimates; it also said that its board of directors has appointed three new members. The global agribusiness and food company posted earnings of $2.52 per share, compared with the prior-year period’s $0.75 per share. Analysts polled by Capital IQ were expecting EPS […]

Integra LifeSciences Q3 Adj. EPS Meets Street View, Revenue Misses Forecast; Tightens FY Revenue Outlook

Integra LifeSciences Holdings (IART) reported pre-market Wednesday Q3 adjusted earnings of $0.59 per share, in line with the analyst consensus and higher than last year’s adjusted earnings of $0.45 per share. The surgical instruments manufacturer generated revenue of $365.9 million, which is up from $278.8 million in the same quarter last year. Analysts polled by CapIQ were expecting revenue of […]

Computacenter Shares Sink as Third Quarter Sales Edge Lower

Shares of Computacenter (CCC.L), a British information technology services provider, traded sharply lower early on Wednesday after revenues fell in the third quarter and the company forecast that while sales in the fourth quarter will improve sequentially, they won’t match the lofty levels seen in the first half. Group turnover, which excludes the two acquisitions that the company made in […]

Carlyle Posts Q3 EPS Miss, Beats on Revenue

The Carlyle Group L.P (CG) reported early Wednesday financial results for Q3, with lower-than-expected earnings and revenue that topped analysts’ estimates; it also approved distributions on common units. The global alternative asset manager posted economic earnings of $0.25 per adjusted unit, excluding one-time items, compared with the prior-year period’s $0.56 per adjusted unit. Analysts polled by Capital IQ were expecting […]

Bristol-Myers Squibb’s Price Target From Berenberg Lifted to $58 From $57

Bristol-Myers Squibb (BMY) received a slight boost to its price target from Berenberg following the pharmaceutical company’s report last week of increased 2018 guidance and better-than-expected Q3 adjusted earnings per share despite weaker-than-expected revenue for the quarter. Berenberg’s new price target on the stock is $58 per share, up from $57. The shares closed Tuesday’s session at $50.02. Berenberg kept […]